ArticleFrontiers in oncology2022

Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models.

Julie Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.